S84409 |
Purvalanol B ( NG 95) |
源葉(MedMol) | 96% |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述: Purvalanol B (NG 95) is a potent, selective, reversible and ATP-competitive inhibitor CDK, with IC50s of 6 nM, 6 nM, 9 nM, 6 nM for cdc2-cyclin B, CDK2-cyclin A, CDK2-cyclin E and CDK5-p35, respectively. Purvalanol B shows selectivity for CDK over a range of other protein kinases (IC50>1000 nM). Purvalanol B inhibits the growth a chloroquine-resistant strain of P. falciparum
- 靶點: cdc2/cyclin B:6 nM (IC50);cdk2/cyclin A:6 nM (IC50);CDK2/cyclinE:9 nM (IC50);CDK5/p35:6 nM (IC50);CDK;?Parasite
- 參考文獻:
1. Gray NS, et, al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998 Jul 24;281(5376):533-8. 2. Bullard KM, et, al. Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites. Malar J. 2015 Apr 8;14:147.
- 溶解性: Soluble in DMSO
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.31 ml 11.55 ml 23.1 ml 5 mM 0.462 ml 2.31 ml 4.62 ml 10 mM 0.231 ml 1.155 ml 2.31 ml 50 mM 0.046 ml 0.231 ml 0.462 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)